SCHEMBL29567146

SCHEMBL29567146

CNC(=O)c1ccc(Cl)c(Oc2cc(-c3c(C)cccc3C)nc(NS(=O)(=O)c3ccccc3)n2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 2/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ PCTP Q9UKL6 2/20 0.42
▸ MEN1 O00255 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ PIK3CD O00329 2/20 0.39
▸ PIK3CA P42336 2/20 0.39
▸ PIK3CG P48736 2/20 0.39
▸ PHGDH O43175 2/20 0.39
▸ PIK3CB P42338 1/20 0.39
▸ PI4KA P42356 1/20 0.39
▸ PIK3C3 Q8NEB9 1/20 0.39
▸ PI4KB Q9UBF8 1/20 0.39
▸ GPR27 Q9NS67 2/20 0.38
▸ PTGDR2 Q9Y5Y4 1/20 0.38
▸ GAA P10253 1/20 0.37
▸ PKM P14618 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24309276 1.00 TSHR (0.44) TSHRSMN1; SMN2PCTPMEN1LMNA
SCHEMBL24310526 0.92 PCTP (0.39) TSHRSMN1; SMN2PCTPMEN1LMNA
SCHEMBL29567195 0.92 PCTP (0.39) TSHRSMN1; SMN2PCTPMEN1LMNA
SCHEMBL29567236 0.92 TSHR (0.46) TSHRSMN1; SMN2PCTPMEN1LMNA
SCHEMBL24309280 0.92 TSHR (0.46) TSHRSMN1; SMN2PCTPMEN1LMNA
SCHEMBL24310316 0.91 TSHR (0.45) TSHRSMN1; SMN2PCTPMEN1LMNA
SCHEMBL29566632 0.91 TSHR (0.45) TSHRSMN1; SMN2PCTPMEN1LMNA
SCHEMBL29566953 0.89 PKM (0.42) SMN1; SMN2PCTPMEN1LMNAMAPT
SCHEMBL26807091 0.89 PKM (0.42) SMN1; SMN2PCTPMEN1LMNAMAPT
SCHEMBL24310281 0.85 FABP4 (0.40) TSHRSMN1; SMN2MEN1LMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225748-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback